website open

Published by naoto.matsuda on

Related Posts

News

EVerMed Inc. received investment from NISSAY CAPITAL CO.,LTD. as the final closing of its seed round.　

January 28, 2024 EVerMed Inc. has raised 180 million yen through a third-party allotment of new shares to Nissay Capital No. 13 Investment Limited Partnership (Chiyoda-ku, Tokyo; General Partner: NISSAY CAPITAL CO.,LTD., President and CEO Read more…

News

EVerMed Inc. received investment from Summit Pharmaceuticals International Corporation (SPI)

October 15, 2024 EVerMed Inc. received investment from SPI as the 2nd closing of its seed round.　With this capital increase, EVerMed will accelerate the development of its pipeline. SPI is a provider of high-quality integrated Read more…

News

EVerMed Inc. has raised 280 million yen in the 1st close of its seed round

August 9, 2024 EVerMed Inc. has raised 280 million yen in the 1st close of its seed round EVerMed Inc. has raised a total of 280 million yen through a third-party allotment of new shares Read more…